Why Siyata Mobile Shares Are Trading Lower By 21%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Portfolio Pulse from Lisa Levin
The article lists the stocks that gained and lost the most in Tuesday's mid-day session. Among the gainers were CytoMed Therapeutics, Adial Pharmaceuticals, and Better Therapeutics, which saw significant increases due to various factors such as favorable regulatory comments and FDA approvals. Among the losers were Journey Medical Corporation, Siyata Mobile, and American Rebel Holdings, which saw significant decreases due to factors such as disappointing trial results and pricing of shares.
July 11, 2023 | 5:26 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
American Rebel Holdings shares declined 20%.
The stock declined significantly, indicating negative market sentiment towards the company.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Journey Medical shares fell 28.9% after the company said its Phase 3 trials achieved co-primary and all secondary endpoints.
Despite achieving trial endpoints, the stock fell significantly, indicating negative market sentiment.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Siyata Mobile shares tumbled 21.1% after the company reported pricing of $2.3 million registered direct of 51,450,000 common shares for $0.045 per share.
The stock fell significantly following the company's pricing announcement, indicating negative market sentiment.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Adial Pharmaceuticals gained 58.2% after the company issued a business update following favorable comments from US and EU regulatory meetings.
The stock gained significantly following favorable regulatory comments, indicating positive market sentiment.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Better Therapeutics shares climbed 42.2% after the FDA approved the company's AspyreRx, a prescription-only digital treatment for type 2 diabetes.
The stock climbed significantly following FDA approval of its product, indicating positive market sentiment.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
CytoMed Therapeutics shares climbed 129.5% after gaining 9% on Monday.
The stock climbed significantly, indicating a positive market sentiment towards the company.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100